Herbs to Homeopathy—Medicinal Products for Children

Gardiner, Paula; Riley, David S.

doi:10.1016/j.pcl.2007.10.005

Cited by 11 publications

(3 citation statements)

References 78 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Interestingly, most participants used dietary supplements in association with pharmacological treatment, and recommendations were based on evidence of their beneficial preventive and therapeutic effects, in contrast to reasons, such as “supplementing the diet” or to “maintain health” when use of supplements is not based on the recommendations of a physician or other health care provider [29]. Of note, the high percentage of pediatricians (54.1%) report the use of homeopathy, which was much greater than those recommending herbal medicinal products (20.3%), despite insufficient evidence and lack of acceptable effectiveness of homeopathy in pediatric patients [31].…”

Section: Discussionmentioning

confidence: 99%

Use of Dietary Supplements among Spanish Pediatricians in Daily Practice: A Cross-Sectional Survey Study

Heras

Santamaria-Orleans

Herrero³

et al. 2019

Journal of Nutrition and Metabolism

View full text Add to dashboard Cite

A cross-sectional survey study was designed to gather information on the use of dietary supplements by Spanish pediatricians. The study questionnaire was completed by 433 pediatricians (62% men, mean age 52.5 years) throughout the country. They also provided data on 10 of their patients (n = 4304) in which synbiotics, immune stimulants, and omega-3 polyunsaturated fatty acids (PUFAs) had been prescribed. Synbiotics were used by 92% of pediatricians, immune stimulants by 80.4%, and omega-3 PUFAs by 75.1%. Synbiotics were mainly used combined with antibiotics (92.6%) and for gastrointestinal disorders (91.2%), immune stimulants to enhance defenses and cold prevention (87.1%), and omega-3 PUFAs to improve symptoms of attention-deficit hyperactivity disorder (ADHD) (84.8%) and concentration (80.1%). Confidence and previous experience with the product (51.6%), composition and indications of the product (43.1%), and tolerability (39.9%) were main factors involved in decision-making. Children treated with omega-3 supplements were significantly older (mean age 7.6 (3.0) years) than those treated with synbiotics (3.9 (3.9) years) or immune stimulants (3.4 (2.8) years) (P<0.001). Short duration of treatment (<1 month) was significantly more common in the synbiotics group (90.5%), whereas longer duration of treatment (>3 months) was more frequent in the omega-3 group (79.1%). In the immune stimulants group, 60.4% of patients were treated for a period between 1 and 3 months. Clinical improvement was rated by participants as “a lot” in 39% of cases and as “quite” improvement in 50.6%. The overall level of satisfaction was rated as “very satisfied” by 52.1% of participants and as “quite satisfied” by 40.9%. The results show that the use of dietary supplements to improve different conditions, particularly minor disorders, is a widespread clinical practice among Spanish pediatricians. Administration regimens for the three types of supplements, synbiotics, immune stimulants, and omega-3 PUFAs, were consistent with guideline recommendations.

show abstract

Section: Discussionmentioning

confidence: 99%

Use of Dietary Supplements among Spanish Pediatricians in Daily Practice: A Cross-Sectional Survey Study

Heras

Santamaria-Orleans

Herrero³

et al. 2019

Journal of Nutrition and Metabolism

View full text Add to dashboard Cite

show abstract

“…This also raises many questions on the amount of information that the patients have to make personal informed decisions [86]. The common practice has been to collect the safety and efficacy information form relatives, magazines and online blogs through the Internet [87][88][89]. It is the responsibility of the clinician to search for information and share it with the patients.…”

Section: Ethical Decisions In Herbal Medicine and Practicementioning

confidence: 99%

Safety, Efficacy, Regulations and Bioethics in Herbal Medicines Research and Practice

Mutua¹,

Juma²,

Munene³

et al. 2016

J Clin Res Bioeth

View full text Add to dashboard Cite

Herbal medicines are used by about 80% of the populations in Africa. Despite being the main management strategy for a number of medical conditions, few studies have been done to suggest their toxicity and efficacy. Moreover, herbal medicines are not prescriptive. Users commonly find information from relatives, and friends. The classification of plant herbal medicines as complementary and alternative medicines also remains to be recognised as nutritional products. This therefore presents a special bioethical challenge in both research and practice for both researchers and medical physicians. Research on herbal medicines also demonstrates the lack of consistency in repeatability and reproducibility of their findings. Some studies have also established efficacy while others demonstrate otherwise. Variation in their findings has been attributed to variations in geographical locations of sources of plant materials and soil diversity. Moreover, ethical consideration in research may not have the appropriate social value, validity in research, risk benefit ratio and collaborations required for ethical sustainability. This may be as a result of the different cultures and traditions in the use of plant materials among different communities. In addition, ethical principles such as beneficence and no malfeasance may not be sustainable for all the medical physicians using plant herbal medicines in the management diseases in patients. The patient autonomy is also not valid table from the existing toxicity and safety studies. More research on bioethics is needed to bridge the gap between ethics, research and practice for herbal medicines.

show abstract

“…S. Trager (Trager, 2005) (Ernst et Cohen, 2001). Régulièrement, les études montrent que les patients obtiennent les informations sur les MAC par des membres de la famille, des amis, des magazines de vulgarisations et d'internet… (Gardiner et Riley, 2007 ;Khader, 2008 ;Low, 2009). Ces moyens d'informations sont considérés comme plutôt peu fiables (De Bruyn, 2001) même si des tentatives émergent pour assurer la robustesse de l'information notamment sur internet (HON@code 7 ).…”

Section: Ethique Et éPidémiologieunclassified

HEDRINE : un nouvel outil d’aide à la décision pour les interactions plante–médicament

Souard

Fortuné

Villier

2014

Le Pharmacien Hospitalier et Clinicien

View full text Add to dashboard Cite

show abstract

Herbs to Homeopathy—Medicinal Products for Children

Cited by 11 publications

References 78 publications

Use of Dietary Supplements among Spanish Pediatricians in Daily Practice: A Cross-Sectional Survey Study

Use of Dietary Supplements among Spanish Pediatricians in Daily Practice: A Cross-Sectional Survey Study

Safety, Efficacy, Regulations and Bioethics in Herbal Medicines Research and Practice

HEDRINE : un nouvel outil d’aide à la décision pour les interactions plante–médicament

Contact Info

Product

Resources

About